Media-OutReach Newswire Wegovy® (semaglutide 2.4mg) by Novo Nordisk is now Available in Singapore for Weight Management
Media-OutReach Newswire Health2Sync and Novo Nordisk Pharma Korea, Ltd. Launch Smart Cap Mallya® for FlexTouch® Insulin Pens Integration in South Korea, Enhancing insulin administration via Digital Diabetes Care
Media-OutReach Newswire Tanoto Foundation Backs Landmark Research to Unlock the Code of Asian Prevalent Diseases
Media-OutReach Newswire Rethinking Obesity: Novo Nordisk’s Latest Initiative Urges Singaporeans to Treat, Not Blame